Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 251–300 of 1,812 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05566834	Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer	unknown	Phase 1	36	Minneamrita Therapeutics LLCINDUSTRY	1	Oct 18, 2023	clinicaltrials
NCT06088459	NWRD06 DNA Plasmid for HCC After Radical Resection	unknown	Phase 1	9	Newish Technology (Beijing) Co., Ltd.INDUSTRY	1	Oct 18, 2023	clinicaltrials